SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-060893
Filing Date
2024-05-14
Accepted
2024-05-14 08:02:25
Documents
14
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414252d1_8k.htm   iXBRL 8-K 26614
2 EXHIBIT 99.1 tm2414252d1_ex99-1.htm EX-99.1 56178
  Complete submission text file 0001104659-24-060893.txt   264888

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20240514.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20240514_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20240514_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2414252d1_8k_htm.xml XML 3688
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 24941509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)